To explore trends in substance use and suicide mortality in the U.S. and identify disparities among different demographics.
Approach:
Data Source: Analysis utilized data from CDC WONDER, removing duplicate ICD-10 codes for accurate mortality counts.
Key Findings:
In 2024, substance use and suicide deaths were the third leading cause of death in the U.S. at 47.7 per 100,000 population.
From 2014 to 2024, mortality rates from substance use and suicide increased from 34.6 per 100,000 to 47.7 per 100,000, peaking at 59.6 per 100,000 in 2021 during the pandemic.
Adults aged 45 to 64, men, and certain communities of color experienced disproportionately high rates of substance use and suicide deaths.
Interpretation:
Despite high mortality rates, access to mental health and substance use services remains challenging, with many insured individuals not receiving needed treatment.
Limitations:
The analysis does not account for all potential factors influencing substance use and suicide rates, such as economic and social factors.
The enforcement of mental health parity laws has been inconsistent, which may impact access to care.
Conclusion:
The findings highlight the urgent need for improved access to mental health and substance use services, particularly among vulnerable populations.
Recent CDC advisories, testing updates, and immunization recommendations highlight developments in infectious diseases, immunization, and diagnostic testing relevant to physicians across multiple specialties.